DK1581239T3 - Tidlig anvendelse af et ekstrakt af røde vinblade - Google Patents

Tidlig anvendelse af et ekstrakt af røde vinblade

Info

Publication number
DK1581239T3
DK1581239T3 DK03782385.3T DK03782385T DK1581239T3 DK 1581239 T3 DK1581239 T3 DK 1581239T3 DK 03782385 T DK03782385 T DK 03782385T DK 1581239 T3 DK1581239 T3 DK 1581239T3
Authority
DK
Denmark
Prior art keywords
extract
red wine
early application
wine leaves
leaves
Prior art date
Application number
DK03782385.3T
Other languages
Danish (da)
English (en)
Inventor
Anke Esperester
Eckhard Schaefer
Fritz Sacher
Holger Kiesewetter
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK1581239T3 publication Critical patent/DK1581239T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
DK03782385.3T 2002-12-31 2003-12-12 Tidlig anvendelse af et ekstrakt af røde vinblade DK1581239T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02029107A EP1435242A1 (en) 2002-12-31 2002-12-31 Method of improvement of blood circulation
PCT/EP2003/014147 WO2004058280A1 (en) 2002-12-31 2003-12-12 Method of improvement of blood circulation

Publications (1)

Publication Number Publication Date
DK1581239T3 true DK1581239T3 (da) 2012-06-11

Family

ID=32479738

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03782385.3T DK1581239T3 (da) 2002-12-31 2003-12-12 Tidlig anvendelse af et ekstrakt af røde vinblade

Country Status (18)

Country Link
EP (2) EP1435242A1 (https=)
JP (1) JP2006516542A (https=)
AT (1) ATE545426T1 (https=)
AU (1) AU2003290031A1 (https=)
BR (1) BR0317895A (https=)
CA (1) CA2512147C (https=)
CY (1) CY1112766T1 (https=)
DK (1) DK1581239T3 (https=)
ES (1) ES2382461T3 (https=)
MX (1) MXPA05007095A (https=)
PE (1) PE20040932A1 (https=)
PL (1) PL215868B1 (https=)
PT (1) PT1581239E (https=)
RU (1) RU2341280C2 (https=)
SI (1) SI1581239T1 (https=)
TW (1) TW200501973A (https=)
UA (1) UA85548C2 (https=)
WO (1) WO2004058280A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007049796A2 (en) 2005-10-26 2007-05-03 Kao Corporation Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver
WO2009027382A2 (de) * 2007-08-31 2009-03-05 Boehringer Ingelheim International Gmbh Sprühfähige zusammensetzung enthaltend extrakt aus rotem weinlaub
DE102008012908A1 (de) * 2008-03-06 2009-09-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg Methode zum anti-inflammatorischen und anti-ödematösen Schutz von explantiertem biologischen Material bis zu seiner Transplantation in Patienten
JP2015224205A (ja) * 2014-05-27 2015-12-14 エスエス製薬株式会社 冷え症等の全身症状改善用経口組成物
KR20200115927A (ko) * 2019-03-29 2020-10-08 주식회사 유니베라 포도잎 추출물 및 병풀 추출물을 포함하는 정맥순환 장애 개선용 조성물
JP7262079B2 (ja) * 2019-06-27 2023-04-21 廉士 澤田 生体センサ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL278161A (https=) * 1961-05-13
FR2276059A1 (fr) * 1974-06-25 1976-01-23 Agronomique Inst Nat Rech Procede d'extraction de pigments vegetaux de la classe des facteurs vitaminiques p a partir de plantes en contenant
JP2001122791A (ja) * 1999-10-20 2001-05-08 Boehringer Ingelheim Internatl Gmbh 下肢の慢性静脈不全の軽減および予防のための赤色ブドウ樹葉の水性抽出物よりなる食事補強剤

Also Published As

Publication number Publication date
PT1581239E (pt) 2012-05-11
SI1581239T1 (sl) 2012-06-29
EP1435242A1 (en) 2004-07-07
CY1112766T1 (el) 2016-02-10
TW200501973A (en) 2005-01-16
UA85548C2 (ru) 2009-02-10
PL378344A1 (pl) 2006-03-20
WO2004058280A1 (en) 2004-07-15
CA2512147A1 (en) 2004-07-15
PL215868B1 (pl) 2014-02-28
JP2006516542A (ja) 2006-07-06
ATE545426T1 (de) 2012-03-15
CA2512147C (en) 2014-09-16
EP1581239A1 (en) 2005-10-05
PE20040932A1 (es) 2004-12-31
EP1581239B1 (en) 2012-02-15
AU2003290031A1 (en) 2004-07-22
ES2382461T3 (es) 2012-06-08
MXPA05007095A (es) 2005-09-12
RU2341280C2 (ru) 2008-12-20
RU2005124164A (ru) 2006-03-20
BR0317895A (pt) 2005-12-06

Similar Documents

Publication Publication Date Title
CY1112766T1 (el) Εγκαιρη χρηση ενος εκχυλισματος απο φυλλα κοκκινης ποικιλιας αμπελου
BRPI0309665B8 (pt) método para analisar uma preparação de alfagalactosidase a
DK1765388T3 (da) Kombinationsterapi til forebyggelse eller behandling af alzheimer's sygdom, og kit dertil
MY146351A (en) Compositions for treating infection in cattle and swine
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
ATE429156T1 (de) Nahrungsergänzung zur behandlung von makula degeneration
BRPI0414565A (pt) composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
DK1594833T3 (da) 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme
CY1107640T1 (el) Μεθοδος για πιστοποιηση παραγοντων για τη θεραπεια διαβητη
EP1505990A4 (en) METHOD FOR THE TREATMENT OF HEPATITIS
NO20062355L (no) Sammensetninger for behandling av sykdom i munnhulen og ovre andedrettssystem
ATE406884T1 (de) Zusammensetzungen mit pantothensäure oder derivaten davon und ihre verwendung zur stimulierung des appetits
DK2172208T3 (da) Små peptider til behandling af alzheimers sygdom og andre beta-amyloidprotein- fibrillogeneseforstyrrelser
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
DE60233433D1 (de) PHARMAZEUTISCHE ZUBEREITUNG enthaltend ein Catechin, Ascorbinsäure, Prolin und Lysin ZUR BEHANDLUNG VON NEOPLASTISCHEN KRANKHEITEN
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
BRPI0411324A (pt) composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
ATE413171T1 (de) Pharmazeutische zusammensetzungen mit ascorbinsäure zur behandlung von pilz- superinfektionen und pilz-rezidiven
AR042682A1 (es) Metodo que mejora la circulacion sanguinea administrando una composicion que contiene un extracto acuoso de hojas de parra roja
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
ITMI20041871A1 (it) Uso di santoreggia satureja montana o dei suoi estratti per la preparazione di medicamenti per il trattamento dell'eiaculazione precoce
DE602004013695D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Hyperhomocysteinämie
ATE348648T1 (de) Synergistische zusammensetzung aus trans-tetracos-15-ensäure und apocynin, und verwendung davon